Lars Dyrskjøt (L Dyrskjøt)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 28

Top Topics

Randomized Controlled Trial

Muscle Invasive Bladder Cancer

Top Venues

Nature communications

Clinical cancer research : an official journal of the American Association for Cancer Research

Nucleus (Austin, Tex.)

This page only lists publications with an associated author ORCID identifier.

Publications

Trine Line Hauge Okholm, Andreas Bjerregaard Kamstrup, Morten Muhlig Nielsen, Anne Kruse Hollensen, Mette Laugesen Graversgaard, Matilde Helbo Sørensen, Lasse Sommer Kristensen, Søren Vang, Samuel S Park, Eugene Yeo, Lars Dyrskjøt, Jørgen Kjems, Jakob Skou Pedersen, Christian Kroun Damgaard
circHIPK3 nucleates IGF2BP2 and functions as a competing endogenous RNA. eLife 13 (2024)
Trine Line Hauge Okholm, Andreas Bjerregaard Kamstrup, Morten Muhlig Nielsen, Anne Kruse Hollensen, Mette Laugesen Graversgaard, Matilde Helbo Sørensen, Lasse Sommer Kristensen, Søren Vang, Samuel S Park, Eugene Yeo, Lars Dyrskjøt, Jørgen Kjems, Jakob Skou Pedersen, Christian Kroun Damgaard
circHIPK3 nucleates IGF2BP2 and functions as a competing endogenous RNA. eLife 13 (2024)
Alexander W Wyatt, Saskia Litière, Francois-Clement Bidard, Luc Cabel, Lars Dyrskjøt, Chris A Karlovich, Klaus Pantel, Joan Petrie, Reena Philip, Hillary S Andrews, Paz J Vellanki, Sofie H Tolmeijer, Xenia Villalobos Alberu, Christian Alfano, Jan Bogaerts, Emiliano Calvo, Helen X Chen, Rodrigo De Almeida Toledo, Elisabeth G E de Vries, Lesley Seymour, Scott A Laurie, Elena Garralda
Plasma ctDNA as a treatment response biomarker in metastatic cancers: evaluation by the RECIST working group. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Sia Viborg Lindskrog, Lars Dyrskjøt
Towards circulating tumor DNA-guided treatment of muscle-invasive bladder cancer. Translational andrology and urology 13 (6) (2024)
Trine Line Hauge Okholm, Andreas Bjerregaard Kamstrup, Morten Muhlig Nielsen, Anne Kruse Hollensen, Mette Laugesen Graversgaard, Matilde Helbo Sørensen, Lasse Sommer Kristensen, Søren Vang, Samuel S Park, Eugene Yeo, Lars Dyrskjøt, Jørgen Kjems, Jakob Skou Pedersen, Christian Kroun Damgaard
circHIPK3 nucleates IGF2BP2 and functions as a competing endogenous RNA. eLife 13 (2024)
D Ranti, H Yu, Y A Wang, C Bieber, T Strandgaard, B Salomé, Sean Houghton, J Kim, H Ravichandran, I Okulate, E Merritt, S Bang, A Demetriou, Z Li, S V Lindskrog, D F Ruan, J Daza, R Rai, E Hegewisch-Solloa, Emily M Mace, R Fernandez-Rodriguez, S Izadmehr, G Doherty, A Narasimhan, A M Farkas, P Cruz-Encarnacion, S Shroff, F Patel, M Tran, S J Park, J Qi, M Patel, D Geanon, G Kelly, R M de Real, B Lee, K Nie, S Miake-Iye, K Angeliadis, E Radkevich, T H Thin, M Garcia-Barros, H Brown, B Martin, A Mateo, A Soto, R Sussman, S Shiwlani, S Francisco-Simon, K G Beaumont, Y Hu, Y-C Wang, L Wang, R P Sebra, S Smith, M Skobe, E Clancy-Thompson, D Palmer, S Hammond, B D Hopkins, P Wiklund, J Zhu, J J Bravo-Cordero, R Brody, B Hopkins, Zhihong Chen, S Kim-Schulze, Lars Dyrskjøt, O Elemento, A Tocheva, W-M Song, N Bhardwaj, M D Galsky, J P Sfakianos, A Horowitz
HLA-E and NKG2A Mediate Resistance to M. bovis BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer. bioRxiv : the preprint server for biology (2024)
Sia Viborg Lindskrog, Lars Dyrskjøt
Towards circulating tumor DNA-guided treatment of muscle-invasive bladder cancer. Translational andrology and urology 13 (6) (2024)
Sofie S Schmøkel, Iver Nordentoft, Sia V Lindskrog, Philippe Lamy, Michael Knudsen, Jørgen Bjerggaard Jensen, Lars Dyrskjøt
Improved protocol for single-nucleus RNA-sequencing of frozen human bladder tumor biopsies. Nucleus (Austin, Tex.) 14 (1) (2023)
Lars Dyrskjøt, Donna E Hansel, Jason Alexander Efstathiou, Margaret A Knowles, Matthew D Galsky, Jeremy Yuen Chun Teoh, Dan Theodorescu
Bladder cancer. Nature reviews. Disease primers 9 (1) (2023)
Sofie S Schmøkel, Iver Nordentoft, Sia V Lindskrog, Philippe Lamy, Michael Knudsen, Jørgen Bjerggaard Jensen, Lars Dyrskjøt
Improved protocol for single-nucleus RNA-sequencing of frozen human bladder tumor biopsies. Nucleus (Austin, Tex.) 14 (1) (2023)
Sia Viborg Lindskrog, Karin Birkenkamp-Demtröder, Iver Nordentoft, Georgios I Laliotis, Philippe Lamy, Emil Christensen, Derrick Renner, Tine G Andreasen, Naja Lange, Shruti Sharma, Adam C ElNaggar, Minetta C Liu, Himanshu Sethi, Alexey Aleshin, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt
Circulating tumor DNA analysis in advanced urothelial carcinoma: insights from biological analysis and extended clinical follow-up. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Iben Lyskjaer, Laura Iisager, Christian Tang Axelsen, Tommy Kjærgaard Nielsen, Lars Dyrskjøt, Niels Fristrup
Management of renal cell carcinoma: promising biomarkers and the challenges to reach the clinic. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Juan Luis García-Rodríguez, Ulrik Korsgaard, Ulvi Ahmadov, Morten T Jarlstad Olesen, Kim-Gwendolyn Dietrich, Emma B Hansen, Stine M Vissing, Benedicte P Ulhøi, Lars Dyrskjøt, Karina Dalsgaard Sørensen, Jørgen Kjems, Henrik Hager, Lasse Sommer Kristensen
Spatial profiling of circular RNAs in cancer reveals high expression in muscle and stromal cells. Cancer research (2023)
Sofie S Schmøkel, Iver Nordentoft, Sia V Lindskrog, Philippe Lamy, Michael Knudsen, Jørgen Bjerggaard Jensen, Lars Dyrskjøt
Improved protocol for single-nucleus RNA-sequencing of frozen human bladder tumor biopsies. Nucleus (Austin, Tex.) 14 (1) (2023)
Emil Christensen, Iver Nordentoft, Karin Birkenkamp-Demtröder, Sara K Elbæk, Sia Viborg Lindskrog, Ann Taber, Tine G Andreasen, Trine Strandgaard, Michael Knudsen, Philippe Lamy, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt
Cell-free urine- and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle invasive bladder cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Trine Line Hauge Okholm, Andreas Bjerregaard Kamstrup, Morten Muhlig Nielsen, Anne Kruse Hollensen, Mette Laugesen Graversgaard, Lasse Sommer Kristensen, Søren Vang, Samuel S Park, Gene W Yeo, Lars Dyrskjøt, Jørgen Kjems, Jakob Skou Pedersen, Christian Kroun Damgaard
circHIPK3 nucleates IGF2BP2 and functions as a competing endogenous RNA. bioRxiv : the preprint server for biology (2023)
Nina Rao, Gabriel J Starrett, Mary L Piaskowski, Kelly E Butler, Yelena Golubeva, Wusheng Yan, Scott M Lawrence, Michael Dean, Montserrat Garcia-Closas, Dalsu Baris, Alison Johnson, Molly Schwenn, Núria Malats, Francisco X Real, Manolis Kogevinas, Nathaniel Rothman, Debra T Silverman, Lars Dyrskjøt, Christopher B Buck, Stella Koutros, Ludmila Prokunina-Olsson
Analysis of several common APOBEC-type mutations in bladder tumors suggests links to viral infection. Cancer prevention research (Philadelphia, Pa.) (2023)
Mateo Sokač, Johanne Ahrenfeldt, Kevin Litchfield, Thomas B K Watkins, Michael Knudsen, Lars Dyrskjøt, Martin Roelsgaard Jakobsen, Nicolai Juul Birkbak
Classifying cGAS-STING Activity Links Chromosomal Instability with Immunotherapy Response in Metastatic Bladder Cancer. Cancer research communications 2 (8) (2022)
Maria S Lindgren, Erik Hansen, Nessn H Azawi, Anna M Nielsen, Lars Dyrskjøt, Jørgen Bjerggaard Jensen
DaBlaCa-13 Study: Oncological Outcome of Short-Term, Intensive Chemoresection With Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Ann Taber, Emil Christensen, Philippe Lamy, Iver Nordentoft, Frederik Prip, Sia Viborg Lindskrog, Karin Birkenkamp-Demtröder, Trine Line Hauge Okholm, Michael Knudsen, Jakob Skou Pedersen, Torben Steiniche, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt
Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis. Nature communications 13 (1) (2022)
A Rouf Banday, Olusegun O Onabajo, Seraph Han-Yin Lin, Adeola Obajemu, Joselin M Vargas, Krista A Delviks-Frankenberry, Philippe Lamy, Ariunaa Bayanjargal, Clara Zettelmeyer, Oscar Florez-Vargas, Vinay K Pathak, Lars Dyrskjøt, Ludmila Prokunina-Olsson
Targeting natural splicing plasticity of APOBEC3B restricts its expression and mutagenic activity. Communications biology 4 (1) (2021)
Ann Taber, Emil Christensen, Philippe Lamy, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt
Reply to: Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy. Nature communications 12 (1) (2021)
Pernille B Elming, Thomas R Wittenborn, Morten Busk, Brita Singers Sørensen, Mathilde Borg Houlberg Thomsen, Trine Strandgaard, Lars Dyrskjøt, Steffen Nielsen, Michael R Horsman
Refinement of an Established Procedure and Its Application for Identification of Hypoxia in Prostate Cancer Xenografts. Cancers 13 (11) (2021)
Sia Viborg Lindskrog, Frederik Prip, Philippe Lamy, Ann Taber, Clarice S Groeneveld, Karin Birkenkamp-Demtröder, Jørgen Bjerggaard Jensen, Trine Strandgaard, Iver Nordentoft, Emil Christensen, Mateo Sokac, Nicolai Juul Birkbak, Lasse Maretty, Gregers G Hermann, Astrid C Petersen, Veronika Weyerer, Marc-Oliver Grimm, Marcus Horstmann, Gottfrid Sjödahl, Mattias Höglund, Torben Steiniche, Karin Mogensen, Aurélien de Reyniès, Roman Nawroth, Brian Jordan, Xiaoqi Lin, Dejan Dragicevic, Douglas G Ward, Anshita Goel, Carolyn D Hurst, Jay D Raman, Joshua I Warrick, Ulrika Segersten, Danijel Sikic, Kim E M van Kessel, Tobias Maurer, Joshua J Meeks, David J DeGraff, Richard T Bryan, Margaret A Knowles, Tatjana Simic, Arndt Hartmann, Ellen C Zwarthoff, Per-Uno Malmström, Núria Malats, Francisco X Real, Lars Dyrskjøt
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. Nature communications 12 (1) (2021)
Ann Taber, Emil Christensen, Philippe Lamy, Iver Nordentoft, Frederik Prip, Sia Viborg Lindskrog, Karin Birkenkamp-Demtröder, Trine Line Hauge Okholm, Michael Knudsen, Jakob Skou Pedersen, Torben Steiniche, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis. Nature communications 11 (1) (2020)
Thomas B K Watkins, Emilia L Lim, Marina Petkovic, Sergi Elizalde, Nicolai Juul Birkbak, Gareth A Wilson, David A Moore, Eva Grönroos, Andrew Rowan, Sally M Dewhurst, Jonas Demeulemeester, Stefan C Dentro, Stuart Horswell, Lewis Au, Kerstin Haase, Mickael Escudero, Rachel Rosenthal, Maise Al Bakir, Hang Xu, Kevin Litchfield, Wei-Ting Lu, Thanos P Mourikis, Michelle Dietzen, Lavinia Spain, George D Cresswell, Dhruva Biswas, Philippe Lamy, Iver Nordentoft, Katja Harbst, Francesc Castro Giner, Lucy R Yates, Franco Caramia, Fanny Jaulin, Cécile Vicier, Ian P M Tomlinson, Priscilla K Brastianos, Raymond J Cho, Boris C Bastian, Lars Dyrskjøt, Göran B Jönsson, Peter Savas, Sherene Loi, Peter J Campbell, Fabrice Andre, Nicholas M Luscombe, Neeltje Steeghs, Vivianne C G Tjan-Heijnen, Zoltan Szallasi, Samra Turajlic, Mariam Jamal-Hanjani, Peter Van Loo, Samuel F Bakhoum, Roland F Schwarz, Nicholas McGranahan, Charles Swanton
Pervasive chromosomal instability and karyotype order in tumour evolution. Nature 587 (7832) (2020)
Joshua J Meeks, Hikmat A Al-Ahmadie, Bishoy Morris Faltas, John A Taylor Iii, Thomas W Flaig, David J DeGraff, Emil Christensen, Benjamin L Woolbright, David J McConkey, Lars Dyrskjøt
Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes. Nature reviews. Urology 17 (5) (2020)
Reidar Albrechtsen, Nicolai J Wewer Albrechtsen, Sebastian Gnosa, Jeanette Schwarz, Lars Dyrskjøt, Marie Kveiborg
Identification of ADAM12 as a Novel Basigin Sheddase. International journal of molecular sciences 20 (8) (2019)